Patient-reported outcomes following treatment with vimseltinib for tenosynovial giant cell tumour in a phase 2 expansion study Meeting Abstract


Authors: Blay, J. Y.; Gelderblom, H.; Rutkowski, P.; Wagner, A. J.; van de Sande, M.; Stacchiotti, S.; Le Cesne, A.; Palmerini, E.; Vallee, M.; Harrow, B.; Becker, C.; Jarecha, R.; Sharma, M.; Tap, W. D.
Abstract Title: Patient-reported outcomes following treatment with vimseltinib for tenosynovial giant cell tumour in a phase 2 expansion study
Meeting Title: ISPOR Europe 2022
Journal Title: Value in Health
Volume: 25
Issue: 12 Suppl.
Meeting Dates: 2022 Nov 6-9
Meeting Location: Vienna, Italy
ISSN: 1098-3015
Publisher: Elsevier Science, Inc.  
Date Published: 2022-12-01
Start Page: S15
Language: English
ACCESSION: WOS:000897594900064
PROVIDER: wos
DOI: 10.1016/j.jval.2022.09.075
Notes: Meeting Abstract: P63 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William Douglas Tap
    377 Tap